Infection in systemic lupus erythematosus

Medecine et Maladies Infectieuses

Volumn 37, Issue 12, 2007, Pages 792-795

  Khalifa, M ^a   Kaabia, N ^a   Bahri, F ^a   Ben Jazia, E ^a   Bouajina, E ^a   Omezzine Letaief, A ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Opportunistic infections; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL ARTHRITIS; CANDIDA ALBICANS; CELLULITIS; COMPARATIVE STUDY; CYSTITIS; DISEASE COURSE; DISEASE SEVERITY; ESOPHAGITIS; FEMALE; HERPES ZOSTER; HUMAN; INFECTION; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MOUTH INFECTION; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; OTITIS; PERITONITIS; PNEUMONIA; PREVALENCE; PYELONEPHRITIS; PYODERMA; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEPTICEMIA; SERUM; SKIN INFECTION; SOFT TISSUE INFECTION; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME SERIES ANALYSIS; UNIVARIATE ANALYSIS; URINARY TRACT INFECTION; BACTERIAL INFECTION; COMMUNICABLE DISEASE; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 36849047310     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2007.07.003     Document Type: Article

References (32)

1. Maddison P.J. Is it SLE?. Best Pract. Res. Clin. Rheumatol. 16 2 (2002) 167-180
2. Ruiz-Irastorza G., Khamasta M.A., Castellino G., and Hughes G.R.V. Systemic lupus erythematosus. Lancet 357 (2001) 1027-1032
3. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. European working party on systemic lupus erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine 82 5 (2003) 299-308
4. Moss K.E., Ioannou Y., Sultan S.M., Haq I., and Isenberg D.A. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann. Rheum. Dis. 61 5 (2002) 409-413
5. Ward M., Pyun E., and Studenski S. Causes of deaths in systemic lupus erythematosus long-term follow-up of an inception Cohort. Arthritis Rheum. 38 10 (1995) 1492-1499
6. Kang I., and Park S.H. Infectious complications in SLE after immunosuppressive therapies. Curr. Opin. Rheumatol. 15 5 (2003) 528-534
7. Fessler B.J. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract. Res. Clin. Rheumatol. 16 2 (2002) 281-291
8. Cohen J., Pinching A.J., Rees A.J., and Peters D.K. Infection and immunosuppression: a study of the infective complications of 75 patients with immunologically-mediated diseases. Q. J. Med. 51 (1982) 1-15
9. Von Graevenitz A. The role of opportunistic bacteria in human disease. Rev. Microbiol. 31 (1997) 447-471
10. Petri M. Infection in systemic lupus erythematosus. Rheum. Dis. Clin. N. Am. 24 (1998) 423-456
11. Pryor B.D., Bolgna S.G., and Kahl L.E. Risk factors for serious infection during treatment with cyclophosphamide and high dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum. 39 (1996) 1475-1482
12. Lacks S., and White P. Morbidity associated with childhood systemic lupus erythematosus. J. Rheumatol. 17 (1990) 941-945
13. Gladman D.D., Hussain F., Ibanez D., and Urowitz M.B. The nature and outcome of infection in systemic lupus erythematosus. Lupus 11 4 (2002) 234-239
14. Zonana-Nacach A., Camargo-Coronel A., Yanez P., Sanchez L., Jimenez-Balderas F.J., and Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10 7 (2001) 505-510
15. Noel V., Lortholary O., Casassus P., Cohen P., Genereau T., Andre M.H., et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann. Rheum. Dis. 60 12 (2001) 1141-1144
16. Sayarlioglu M., Inanc M., Kamali S., Cefle A., Karaman O., Gul A., et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13 4 (2004) 274-278
17. Tam L.S., Li E.K., Wong S.M., and Szeto C.C. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand. J. Rheumatol. 31 5 (2002) 296-300
18. Balakrishnan C., Mangat G., Mittal G., and Joshi V.R. Tuberculosis in patients with systemic lupus erythematosus. J. Assoc. Physicians India 46 8 (1998) 682-683
19. Feng P.H., and Tan T.H. Tuberculosis in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 41 1 (1982) 11-14
20. Ortmann R.A., and Klippel J.H. Update on cyclophosphamide for systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26 2 (2000) 363-375
21. Ishikawa O., Abe M., and Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin. Exp. Dermatol. 24 4 (1999) 327-328
22. Kahl L.E. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J. Rheumatol. 21 1 (1994) 84-86
23. Garred P., Madsen H.O., Halberg P., Petersen J., Kronborg G., Svejgaard A., et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 42 10 (1999) 2145-2152
24. Iliopoulos A.G., and Tsokos G.C. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin. Arthritis Rheum. 25 5 (1996) 318-336
25. Bartholomew W.R., and Shanahan T.C. Complement components and receptors: deficiencies and disease associations. Immunol. Ser. 52 (1990) 33-51
26. Piliero P., and Furie R. Functional asplenia in systemic lupus erythematosus. Semin. Arthritis Rheum. 20 3 (1990) 185-189
27. Badsha H., Kong K.O., Lian T.Y., Chan S.P., Edwards C.J., and Chng H.H. Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications. Lupus 11 8 (2002) 508-513
28. Illei G.G., Austin H.A., Crane M., Collins L., Gourley M.F., Yarboro C.H., et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann. Intern. Med. 135 4 (2001) 248-257
29. Ginzler E., Diamond H., Kaplan D., Weiner M., Schlesinger M., and Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 21 1 (1978) 37-44
30. Petri M., and Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J. Rheumatol. 19 10 (1992) 1559-1565
31. Paton N.I., Cheong I.K., Kong N.C., and Segasothy M. Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 89 7 (1996) 531-538
32. Howe H.S., Boey M.L., and Feng P.H. Methylprednisolone in systemic lupus erythematosus. Singapore Med. J. 31 1 (1990) 18-21